Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelfinavir with Proton Beam Radiotherapy for Stage III NSCLC
NCT01108666Phase 2Terminated
- Sponsor
- Abramson Cancer Center
- Start
- Mar 2010
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nelfinavir in non-small cell lung cancer (NSCLC), sponsored by Abramson Cancer Center. Started Mar 2010; status: terminated.
02
Drugs
nelfinavir
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01108666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01108666.